Microbial Testing

Microbial Testing Market by Product (Instruments, Reagents), Application (Chemical & Material Manufacturing, Clinical, Energy), End-User - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the microbial testing market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[192 Pages Report] The Microbial Testing Market size was estimated at USD 3.76 billion in 2023 and expected to reach USD 4.29 billion in 2024, at a CAGR 14.81% to reach USD 9.90 billion by 2030.

Microbial Testing Market
To learn more about this report, request a free PDF copy

Microbiology testing is an analytical technique used to determine the microorganisms in numerous samples such as biological, food & beverage, and environmental samples. Microbiology testing uses chemical, biological, molecular, and biochemical methods and is applied to disease-causing and spoilage microorganisms. As per World Health Organization (WHO), around 7 million people get infected by influenza in the United States every year, creating a huge scope of growth for research and development proficiencies associated with microbiology testing. Several new government policies in enhancing the diagnostic and testing processes led to the growth of microbiology testing, as it is an essential component in testing viruses. However, concerns related to microbial testing instruments recall and the shortage of skilled workforce significantly impedes the utilization of microbial testing. In addition, emerging technological advancements in microbial testing technologies and improved medical infrastructures in hospitals and clinical labs are expected to create robust opportunities for developing the microbial testing market. Several newly developed molecular diagnostic methods such as real-time PCR, NGS, molecular cartridges, and PCR combined with mass spectrometry are employed for early identification and efficient treatment of pathogen-borne disorders and to analyze multiple samples in a single run.

Microbial Testing Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Product: Suitability of reagents for high-throughput settings and detecting low-abundance pathogens

Microbial testing instruments are pivotal for accurate, efficient, and rapid microbial analysis in various industries, including pharmaceuticals, food & beverages, clinical diagnostics, and environmental testing. These instruments encompass a vast array of products, such as incubators, bacterial colony counters, microbial air samplers, and real-time PCR machines. The preference for microbial testing instruments often hinges on the specific requirements of the application, such as sensitivity, speed, and the need for automation. Reagents are essential for microbial testing, serving as the chemical substances or mixtures used to detect, quantify, and examine microbial presence or activity. They include media, stains, indicators for microbial growth, and kits for specific pathogen detection. The selection of reagents is determined by the target microorganism, the sample's nature, and the required sensitivity and specificity. High-risk industries, including food safety and clinical diagnostics, opt for high-quality, validated reagents to ensure the reliability of results.

End-User: Need for microbial testing with improved flexibility and comprehensiveness in hospitals

Academic and research institutes primarily engage in microbial testing for purposes of study, research, and development. Their focus often leans toward cutting-edge, innovative methods for microbial detection, identification, and enumeration. These institutions prioritize the accuracy, sensitivity, and specificity of the test methods, along with the adaptability to a wide range of research settings. Hospitals and diagnostic centers require fast, reliable, and highly accurate microbial testing solutions to diagnose infections and prevent hospital-acquired infections (HAIs). Hospitals prefer automated, high-throughput systems that can handle large sample volumes efficiently and provide rapid results for clinical decision-making. Lab service providers, ranging from small, specialized labs to large reference laboratories, require flexible and scalable microbial testing solutions. Their needs encompass a broad spectrum from basic microbial counts to advanced pathogen identification, catering to diverse clients such as food and beverage companies, environmental agencies, and pharmaceutical firms.

Regional Insights

In North America, huge healthcare facilities, increasing investment from major market players in the growth of advanced devices, well-established distribution channels for clinical microbiology product manufacturers, and a growing number of research activities boost the utilization of microbial testing methods. According to the National Institutes of Health (NIH), in May 2022, the funding for antimicrobial resistance research increased from USD 656 million in 2021 to USD 665 million in 2022. Such increasing investment in research by the government is propelling the growth of the microbiology testing market in the region. The rising government initiatives to raise awareness and favorable regulatory policies to increase the adoption rate for microbiology testing and the higher demand for quality healthcare facilities in the Asia-Pacific region enhance the adoption of microbial testing for various applications. In May 2022, Merck India established a Microbial Application Training lab (MATLab) in Bangalore for academic and commercial objectives. The lab invites Merck and other pharma and biopharma companies to work together to build up their skills for microbial investigation. The microbiological testing market is developing in Europe owing to technological developments, increasing infectious illnesses and epidemic outbreaks, rising healthcare costs, and expanding private-public support for infectious disease research. The rapidly growing geriatric population, growth in clinical research studies in clinical microbiology, and increasing funding, research grants, and investments are key factors influencing microbiology testing across Europe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Microbial Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Microbial Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Bruker Introduced New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper, and a Novel LiquidArray Gastrointestinal Syndromic Panel

    Bruker, a leading manufacturer of scientific instruments for molecular and materials research, introduced new In Vitro Diagnostic (IVD) solutions for microbial testing. The innovative MALDI Biotyper system included a comprehensive database to identify medically relevant Mycobacteria and Fungi strains. With the growing threat of antibiotic-resistant infections, this development is crucial for accurate and timely identification of pathogens. Additionally, Bruker has launched a novel LiquidArray Gastrointestinal Syndromic Panel for simultaneous detection and identification of multiple enteric pathogens. These products demonstrate Bruker's commitment to advancing microbial testing technology to enable better patient outcomes. [Published On: 2023-04-14]

  • Nelson Labs receives ASCA accreditation from FDA

    Nelson Labs achieved another milestone in the field of microbial testing. The laboratory recently obtained accreditation from the Accreditation Scheme for Conformity Assessment (ASCA) and certification from the U.S. Food and Drug Administration (FDA). This is a testament to the laboratory's dedication to providing high-quality testing services that meet industry standards. With this new accreditation and certification, customers can have greater confidence and trust in the accuracy and reliability of Nelson Labs' testing results. This achievement showcases Nelson Labs' commitment to constantly improving its processes and services, and it is sure to be a valuable asset in the competitive world of microbial testing. [Published On: 2023-04-12]

  • SGS’s New Agri-Commodity and Food Testing Laboratory in Brazil Received ISO 17025 and AOAC International Accreditation

    SGS, a inspection, verification, testing, and certification company, opened a new agri-commodity and food testing laboratory in Brazil. This modern lab is equipped with state-of-the-art technology and offers a broad range of testing services, including microbial testing. As the importance of food safety continues to grow, the demand for microbial testing has also increased. SGS's expert team of microbiologists use their knowledge and expertise to provide accurate and timely results to ensure that food products meet the necessary safety standards. With this new facility, SGS is committed to providing reliable services that help organizations comply with regulatory requirements and protect consumer health. [Published On: 2023-03-27]

Key Company Profiles

The report delves into recent significant developments in the Microbial Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Accepta Ltd., AEMTEK Laboratories, Agilent Technologies, Inc., ALS Limited, ARL Bio Pharma, Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMérieux SA, Biosan Laboratories, Inc., Bruker Corporation, Charles River Laboratories, Döhler GmbH, Ecolyse, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Intertek Group PLC, LuminUltra Technologies Ltd., Medicinal Genomics Corp., Merck KGaA, Microbac Laboratories Inc., Nelson Laboratories, LLC, NEOGEN Corporation, QIAGEN N.V., Sartorius AG, SGS S.A., Shimazdu Corporation, Thermo Fisher Scientific Inc., and TÜV SÜD.

Market Segmentation & Coverage

This research report categorizes the Microbial Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents
  • Application
    • Chemical & Material Manufacturing
    • Clinical
      • Bloodstream Infections
      • Gastrointestinal Diseases
      • Periodontal Diseases
      • Respiratory Diseases
      • Sexually Transmitted Diseases
      • Urinary Tract Infections
    • Energy
    • Environment
    • Food Testing
    • Pharmaceutical
  • End-User
    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Lab Service Providers

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Microbial Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Microbial Testing Market?
  3. What are the technology trends and regulatory frameworks in the Microbial Testing Market?
  4. What is the market share of the leading vendors in the Microbial Testing Market?
  5. Which modes and strategic moves are suitable for entering the Microbial Testing Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Microbial Testing Market, by Product
  7. Microbial Testing Market, by Application
  8. Microbial Testing Market, by End-User
  9. Americas Microbial Testing Market
  10. Asia-Pacific Microbial Testing Market
  11. Europe, Middle East & Africa Microbial Testing Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 386]
  16. List of Companies Mentioned [Total: 31]
Unmask Microorganisms with the Power of Microbial Testing
September 10, 2023
INSIGHT
Unmask Microorganisms with the Power of Microbial Testing
Microorganisms have a profound impact on human life, both positive and negative. Microbial testing allows identifying and understanding these organisms to harness their potential while reducing their detrimental effects.

In a world where the naked eye can only perceive so much, the realm of microbiology opens up a fascinating and often unseen universe. Microbial testing is a cornerstone of this realm, bringing to light the hidden world of microorganisms that shape our environment, health, and industries. It has wide applications in unmasking health hazards in the public health sector, maintaining quality assurance in industries such as pharmaceuticals, cosmetics, and food & beverage, providing environmental insights through analysis of soil, water, and air, and harnessing the power of probiotics by identification of useful microorganisms.

Technological advancements have revolutionized microbial testing to accelerate testing processes and give a comprehensive view of the microbial communities. These advances have increased the speed, accuracy, and efficiency of microbial analysis while making it more cost-effective for industries. In June 2023, LuminUltra Technologies Ltd. launched a user-friendly test kit, BugCount Fuel, to swiftly and accurately assess fuel microbial contamination for industries such as marine and aviation.

Machine learning and artificial intelligence (AI) applications have also infiltrated the microbial testing arena, expediting data analysis and interpretation. Microbial testing holds immense significance in multiple facets of human life. With the unraveling of the mysteries of the microbial world, doors to new applications and discoveries are expected to open.

Microbial Testing in Pharmaceutical Industry
June 22, 2023
BLOG
Microbial Testing in Pharmaceutical Industry
Microbial testing has become a crucial part of quality control in the pharmaceutical industry. With the surge in pharmaceutical research and the focus on microbiological quality control, microbial testing has gained increased attention and importance. Microbial contamination can have severe effects on drugs that are meant to cure diseases and improve health. Hence, it is essential to ensure the microbial quality of pharmaceutical products. This blog post will discuss the importance of microbial testing, the different types of tests, and the regulatory guidelines that companies need to follow.

Importance of Microbial Testing:

As mentioned earlier, microbial contamination can lead to serious consequences for drugs. Contaminated drugs can cause infections, medical complications, and even death. Hence, microbial testing is crucial to ensure that finished drugs or active pharmaceutical ingredients have met the regulatory standards for microbial quality.

Microbial testing also helps in detecting any contamination sources during the drug manufacturing process. Early detection of contamination sources can help identify and rectify the issue before it escalates. This, in turn, can help prevent production delays and save costs.

Types of Microbial Tests:

There are various types of microbial tests done to detect the presence of microorganisms. These tests can be classified based on the type of microorganisms or the type of samples tested.

Some of the commonly used tests in the pharmaceutical industry are:

Bacterial endotoxin test: This test detects the presence of bacterial endotoxins in pharmaceutical products.
Total aerobic microbial count: This test measures the total number of microorganisms present in a sample.
Preservative efficacy test: This test determines if the preservatives used in the formulation of pharmaceutical products are effective in preventing microbial growth.
Sterility test: This test detects the presence of any viable microorganisms in a sterile pharmaceutical product.

Regulatory Guidelines:

Regulatory agencies such as the FDA and the European Medicines Agency (EMA) have specific guidelines that pharmaceutical companies must follow for microbial testing. These guidelines ensure that the products are safe for use and meet regulatory standards.

For example, the FDA requires that all sterile pharmaceutical products undergo a sterility test before they can be marketed. The EMA requires a preservative efficacy test for multi-dose products to ensure that they are safe and effective.

Microbial testing is a critical aspect of quality control in the pharmaceutical industry. It helps in ensuring that the finished drugs or active pharmaceutical ingredients meet the regulatory standards for microbial quality. Pharmaceutical companies must follow the guidelines set by regulatory agencies to ensure safe and effective products.

With the increased focus on microbiological quality control, the scope of microbial testing in the pharmaceutical industry has widened. It has become essential for companies to invest in high-quality microbial testing methods, equipment, and expertise to ensure the quality of their products.

Frequently Asked Questions
  1. How big is the Microbial Testing Market?
    Ans. The Global Microbial Testing Market size was estimated at USD 3.76 billion in 2023 and expected to reach USD 4.29 billion in 2024.
  2. What is the Microbial Testing Market growth?
    Ans. The Global Microbial Testing Market to grow USD 9.90 billion by 2030, at a CAGR of 14.81%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.